Next Article in Journal
SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model
Next Article in Special Issue
Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
Previous Article in Journal
Acceptance of Booster COVID-19 Vaccine and Its Association with Components of Vaccination Readiness in the General Population: A Cross-Sectional Survey for Starting Booster Dose in Japan
Previous Article in Special Issue
Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine
 
 
Review

Article Versions Notes

Vaccines 2022, 10(7), 1103; https://doi.org/10.3390/vaccines10071103
Action Date Notes Link
article pdf uploaded. 9 July 2022 11:47 CEST Version of Record https://www.mdpi.com/2076-393X/10/7/1103/pdf-vor
article pdf uploaded. 9 July 2022 12:12 CEST Updated version of record https://www.mdpi.com/2076-393X/10/7/1103/pdf-vor
article xml file uploaded 11 July 2022 09:05 CEST Original file -
article xml uploaded. 11 July 2022 09:05 CEST Update https://www.mdpi.com/2076-393X/10/7/1103/xml
article pdf uploaded. 11 July 2022 09:05 CEST Updated version of record https://www.mdpi.com/2076-393X/10/7/1103/pdf
article html file updated 11 July 2022 09:06 CEST Original file -
article html file updated 11 July 2022 10:06 CEST Update -
article html file updated 13 August 2022 00:59 CEST Update https://www.mdpi.com/2076-393X/10/7/1103/html
Back to TopTop